Sol J. Barer

Sol J. Barer discloses dealings in 3 companies, chiefly NexImmune, Inc., Teva Pharmaceutical Industries Ltd and InspireMD, Inc. Over a trading history stretching from 26 January 2016 to 5 June 2026, the count stands at 16 filings.

The open-market record is one-sided, with 7 purchases and not one sale. No amount is published for 7 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant and 8 option exercises.

On 8 June 2026 came the latest disclosure, an option exercise in Teva Pharmaceutical Industries Ltd. The most recent open-market purchase was published on 31 March 2023, 1,297 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.